No Data
No Data
No Data
Nine companies, including SF Express, Aggregate Data, Jinyuan Hydrogen Energy, Weisheng Pharmaceutical, Shenghe Biotech, Egg, and Baide Medical, are planning to be listed in Hong Kong/US to file supplementary material requirements (feedback)
Requirements for supplementary materials for overseas issuance and listing registration (September 15, 2023 to September 21, 2023)
IPO News | Ma Long Dental's proposed Hong Kong stock IPO, China Securities Regulatory Commission requires explanation of changes in equity and major asset acquisitions
On September 22, the China Securities Regulatory Commission issued a public announcement on the requirements for supplementary materials for overseas issuance and listing registration (September 15, 2023 to September 21, 2023)
IPO Preview|Ma Long Dental's IPO in Hong Kong: Each dentist earns an average income of 2.4 million yuan
Focusing on the fundamentals of Umataki Dental Clinic, it is easy to see that “steady revenue growth and poor profit conditions” is a shadow that pervades the hearts of many investors.
[IPO] Ma Long Medical Management (Zhejiang) submits listing application to Hong Kong Stock Exchange
According to the Hong Kong Stock Exchange's disclosure on August 22, Ma Long Medical Management (Zhejiang) submitted a listing application to the Hong Kong Stock Exchange, and Haitong International is the exclusive sponsor. According to the prospectus, the company is a leading high-end private dental service provider in China and has a highly standardized and replicable business model. According to the Frost & Sullivan Report, in terms of revenue in 2022, the company ranked 9th among all private dental care service providers in China and 2nd among all high-end private dental service providers in China. On the financial side, In 2020, 2021, 2022, and up to 2022 and 2024
No Data
No Data